Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
    • Index
    • Overview and Device Description
    • Information provided by the Manufacturer
    • Design and Manufacturing Information
    • GSPR
    • Benefit-Risk Analysis and Risk Management
    • Product Verification and Validation
      • Software
      • Artificial Intelligence
      • Usability and Human Factors Engineering
      • Clinical
        • Evaluation
          • R-TF-015-001 Clinical Evaluation Plan
          • R-TF-015-003 Clinical Evaluation Report
          • R-TF-015-007 Delaration of interest Alberto Sabater
          • R-TF-015-007 Delaration of interest Alfonso Medela
          • R-TF-015-007 Delaration of interest Constanza Balboni
          • R-TF-015-007 Delaration of interest María Belén Hirigoity
          • R-TF-015-007 Delaration of interest María Diez
          • R-TF-015-007 Delaration of interest Taig Mac Carthy
        • Investigation
        • R-TF-015-008 Clinical development plan
    • Design History File
    • Post-Market Surveillance
  • Legit.Health Plus Version 1.1.0.1
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • Grants
  • Public tenders
  • Legit.Health Plus Version 1.1.0.0
  • Product Verification and Validation
  • Clinical
  • Evaluation

Evaluation

📄️ R-TF-015-001 Clinical Evaluation Plan

Purpose

📄️ R-TF-015-003 Clinical Evaluation Report

Executive summary

📄️ R-TF-015-007 Delaration of interest Alberto Sabater

Declaration of interest

📄️ R-TF-015-007 Delaration of interest Alfonso Medela

Declaration of interest

📄️ R-TF-015-007 Delaration of interest Constanza Balboni

📄️ R-TF-015-007 Delaration of interest María Belén Hirigoity

📄️ R-TF-015-007 Delaration of interest María Diez

Declaration of interest

📄️ R-TF-015-007 Delaration of interest Taig Mac Carthy

Declaration of interest

Previous
Clinical
Next
R-TF-015-001 Clinical Evaluation Plan
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)